共 59 条
[1]
Koch-Weser J., Serum drug concentrations as therapeutic guides, N Engl J Med, 287, pp. 227-231, (1972)
[2]
Koch-Weser J., The serum level approach to individualization of drug dosage, Eur J Clin Pharmacol, 9, pp. 1-8, (1975)
[3]
Pippenger C.E., Therapeutic drug monitoring: An overview, Ther Drug Monitoring, 1, pp. 3-9, (1979)
[4]
Glassman A.H., Perel J.M., Tricyclic blood levels and clinical outcome: A review of the art, Psychopharmacology: A Generation of Progress, pp. 917-922, (1978)
[5]
Asberg M., Treatment of depression with tricyclic drugs—Pharmacokinetic and pharmacodynamic aspects, Pharmakopsych Neuro-Psychopharmakol, 9, pp. 18-26, (1979)
[6]
Gram L.F., Reisby N., Ibsen I., Nagy A., Dencker S.J., Bech P., Petersen G.O., Christiansen J., Plasma levels and antidepressant effect of imipramine, Clin Pharmacol Ther, 19, pp. 318-324, (1976)
[7]
Boethius G., Sjoqvist F., Doses and dosage intervals of drugs—Clinical practice and pharmacokinetic principles, Clin Pharmacol Ther, 24, pp. 255-263, (1978)
[8]
Braithwaite R., Montgomery S., Dawling S., Nortriptyline in depressed patients with high plasma levels. II, Clin Pharmacol Ther, 23, pp. 303-308, (1978)
[9]
Ziegler V.E., Wylie L.T., Biggs J.T., Intrapatient variability of serial steady-state plasma tricyclic antidepressant concentrations, J Pharm Sci, 67, pp. 554-555, (1978)
[10]
Biggs J.T., Chang S.S., Sherman W.R., Holland W.H., Measurement of tricyclic antidepressant levels in an outpatient clinic, J Nerv Ment Dis, 162, pp. 46-51, (1976)